. . . . . . . . . . . . . . "Targeting the MMP-14/MMP-2/integrin \u03B1\u03B2 axis with multispecific N-TIMP2-based antagonists for cancer therapy"@en . . . . . . . . . . "34" . . . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 \u0432 \u0441\u0435\u0440\u043F\u043D\u0456 2018"@uk . . . . . . "Niv Papo" . . . . . . . . . . . "Targeting the MMP-14/MMP-2/integrin \u03B1\u03B2 axis with multispecific N-TIMP2-based antagonists for cancer therapy"@en . . . "wetenschappelijk artikel"@nl . . . . . . "Targeting the MMP-14/MMP-2/integrin \u03B1\u03B2 axis with multispecific N-TIMP2-based antagonists for cancer therapy"@nl . . . "im August 2018 ver\u00F6ffentlichter wissenschaftlicher Artikel"@de . "art\u00EDculu cient\u00EDficu"@ast . "293" . . . . . . . . . . . . . . . "6109916" . . . . . . . . . "2018-08-24T00:00:00Z"^^ . . . . . . . . . . . . "13310-13326" . . "29986882" . . . . . . . . . . . . . . . "scientific article published in Journal of Biological Chemistry"@en . . . "Valeria Arkadash" . . . . "Gal Yosef" . . . . . . . . . . . . "Targeting the MMP-14/MMP-2/integrin \u03B1\u03B2 axis with multispecific N-TIMP2-based antagonists for cancer therapy"@nl . . . "Targeting the MMP-14/MMP-2/integrin \u03B1\u03B2 axis with multispecific N-TIMP2-based antagonists for cancer therapy"@en . . . . . . . . . . . . . . . . . . . . . . . . "10.1074/JBC.RA118.004406" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "Targeting the MMP-14/MMP-2/integrin \u03B1\u03B2 axis with multispecific N-TIMP2-based antagonists for cancer therapy"@en . . . . . . . . . "article publi\u00E9 dans la revue scientifique Journal of Biological Chemistry"@fr . . "Targeting the MMP-14/MMP-2/integrin \u03B1\u03B2 axis with multispecific N-TIMP2-based antagonists for cancer therapy"@nl . .